{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:31:30Z","timestamp":1761294690284,"version":"3.37.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160809","82060396"],"award-info":[{"award-number":["82160809","82060396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2018GXNSFBA281090","2017GXNSFAA198305"],"award-info":[{"award-number":["2018GXNSFBA281090","2017GXNSFAA198305"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Talent Training Program of Guangxi-Collaborative Innovation Center for Biomedicine","award":["0240622005C"],"award-info":[{"award-number":["0240622005C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Legg-Calv\u00e9-Perthes disease is a special self-limited disease in pediatric orthopedics with a high disability rate and a long-term course, and there is still no clear and effective therapeutic drug in clinic. This study aimed to investigate the potential efficacy of biochanin A, a kind of oxygen-methylated isoflavone compound, in treating Perthes disease based on network pharmacology, molecular docking and in vitro experiments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>IL-6 was used to stimulate human umbilical vein endothelial cells to construct endothelial cell dysfunction model. We demonstrated whether biochanin A could alleviate endothelial dysfunction through CCK8 assay, immunofluorescence. Targets of biochanin A from pharmMappeer, SWISS, and TargetNet databases were screened. Targets of endothelial dysfunction were obtained from Genecards and OMIM databases. Protein\u2013protein interaction, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomics analyses were used to analyze the potential target and the key pathway of the anti-endothelial dysfunction activity of biochanin A. To validate the potential target-drug interactions, molecular docking and molecular dynamics simulations were performed and the result was proved by western blot.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>It was found that biochanin A can promote the expression of ZO-1, reduce the expression of ICAM-1, which means improving endothelial dysfunction. A total of 585 targets of biochanin A from pharmMappeer, SWISS, and TargetNet databases were screened. A total of 10,832 targets of endothelial dysfunction were obtained from Genecards and OMIM databases. A total of 527 overlapping targets of endothelial dysfunction and biochanin A were obtained. AKT1, TNF-\u03b1, VCAM1, ICAM1, and NOS3 might be the key targets of the anti-endothelial dysfunction activity of biochanin A, and the key pathways might be PI3K-Akt and TNF signaling pathways. Molecular docking results indicated that the AKT1 and TNF-\u03b1 had the highest affinity binding with biochanin A.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study indicates that biochanin A can target AKT1 and TNF-\u03b1 to alleviate endothelial dysfunction induced by IL-6 in Perthes disease, which provides a theoretical basis for the treatment of Perthes disease by using biochanin A.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-04298-w","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T06:02:46Z","timestamp":1704780166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calv\u00e9-Perthes disease based on network pharmacology and molecular docking"],"prefix":"10.1186","volume":"24","author":[{"given":"Jianhong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirui","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengsen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"3","key":"4298_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5312\/wjo.v10.i3.145","volume":"10","author":"V Pavone","year":"2019","unstructured":"Pavone V, Chisari E, Vescio A, Lizzio C, Sessa G, Testa G. Aetiology of Legg-Calv\u00e9-Perthes disease: a systematic review. World journal of orthopedics. 2019;10(3):145\u201365.","journal-title":"World journal of orthopedics"},{"issue":"5","key":"4298_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11999.0000000000000214","volume":"476","author":"Y Hailer","year":"2018","unstructured":"Hailer Y, Hailer N. Is Legg-Calv\u00e9-Perthes disease a local manifestation of a systemic condition? Clin Orthop Relat Res. 2018;476(5):1055\u201364.","journal-title":"Clin Orthop Relat Res"},{"doi-asserted-by":"crossref","unstructured":"Aksoy M, Aksoy D, Haznedaroglu I, Sayinalp N, Kirazli S, Alpaslan MJH. Thrombomodulin and GFC levels in Legg-Calve-Perthes disease. 2008;13(6):324-8.","key":"4298_CR3","DOI":"10.1179\/102453308X343509"},{"issue":"1","key":"4298_CR4","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1542\/peds.2011-3269","volume":"130","author":"D Perry","year":"2012","unstructured":"Perry D, Green D, Bruce C, Pope D, Dangerfield P, Platt M, et al. Abnormalities of vascular structure and function in children with Perthes disease. Pediatrics. 2012;130(1):e126\u201331.","journal-title":"Pediatrics"},{"key":"4298_CR5","doi-asserted-by":"publisher","first-page":"118749","DOI":"10.1016\/j.lfs.2020.118749","volume":"265","author":"B Li","year":"2021","unstructured":"Li B, Huang Q, Lin C, Lu R, Wang T, Chen X, et al. Increased circulating CD31+\/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction. Life Sci. 2021;265:118749.","journal-title":"Life Sci"},{"key":"4298_CR6","doi-asserted-by":"publisher","first-page":"652008","DOI":"10.3389\/fonc.2021.652008","volume":"11","author":"Q Dong","year":"2021","unstructured":"Dong Q, Li Q, Duan L, Yin H, Wang X, Liu Y, et al. viaBiochanin A Inhibits Glioblastoma Growth Restricting Glycolysis and Mitochondrial Oxidative Phosphorylation. Front Oncol. 2021;11:652008.","journal-title":"Front Oncol"},{"issue":"6","key":"4298_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3892\/etm.2020.9381","volume":"20","author":"S Zhang","year":"2020","unstructured":"Zhang S, Niu Y, Yang Z, Zhang Y, Guo Q, Yang Y, et al. Biochanin A alleviates gingival inflammation and alveolar bone loss in rats with experimental periodontitis. Exp Ther Med. 2020;20(6):251.","journal-title":"Exp Ther Med"},{"key":"4298_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.fct.2017.12.062","volume":"112","author":"Y Hsu","year":"2018","unstructured":"Hsu Y, Shyu H, Hu T, Yeh J, Lin Y, Lee L, et al. Anti-proliferative activity of biochanin A in human osteosarcoma cells via mitochondrial-involved apoptosis. Food Chem Toxicol. 2018;112:194\u2013204.","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"4298_CR9","doi-asserted-by":"publisher","first-page":"e115115","DOI":"10.1371\/journal.pone.0115115","volume":"9","author":"L Hanski","year":"2014","unstructured":"Hanski L, Genina N, Uvell H, Malinovskaja K, Gylfe \u00c5, Laaksonen T, et al. Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation. PLoS ONE. 2014;9(12):e115115.","journal-title":"PLoS ONE"},{"issue":"4","key":"4298_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/biof.1514","volume":"45","author":"F Liang","year":"2019","unstructured":"Liang F, Cao W, Huang Y, Fang Y, Cheng Y, Pan S, et al. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells. BioFactors (Oxford, England). 2019;45(4):563\u201374.","journal-title":"BioFactors (Oxford, England)"},{"key":"4298_CR11","doi-asserted-by":"publisher","first-page":"646720","DOI":"10.3389\/fendo.2021.646720","volume":"12","author":"M Guo","year":"2021","unstructured":"Guo M, Qu S, Lu H, Wang W, He M, Su J, et al. In VivoBiochanin A Alleviates Cerebral Ischemia\/Reperfusion Injury by Suppressing Endoplasmic Reticulum Stress-Induced Apoptosis and p38MAPK Signaling Pathway and. Front Endocrinol. 2021;12:646720.","journal-title":"Front Endocrinol"},{"key":"4298_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lfs.2015.06.015","volume":"136","author":"X Ming","year":"2015","unstructured":"Ming X, Ding M, Zhai B, Xiao L, Piao T, Liu M. Biochanin A inhibits lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells. Life Sci. 2015;136:36\u201341.","journal-title":"Life Sci"},{"issue":"2","key":"4298_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3892\/ijmm.2014.2020","volume":"35","author":"W Wu","year":"2015","unstructured":"Wu W, Wu Y, Huang H, He C, Li W, Wang H, et al. Biochanin A attenuates LPS-induced pro-inflammatory responses and inhibits the activation of the MAPK pathway in BV2 microglial cells. Int J Mol Med. 2015;35(2):391\u20138.","journal-title":"Int J Mol Med"},{"issue":"4","key":"4298_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbrc.2016.06.126","volume":"477","author":"J Oh","year":"2016","unstructured":"Oh J, Cho I, Kang K, You J, Yu S, Lee G, et al. Biochanin-A antagonizes the interleukin-1\u03b2-induced catabolic inflammation through the modulation of NF\u03baB cellular signaling in primary rat chondrocytes. Biochem Biophys Res Commun. 2016;477(4):723\u201330.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4298_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jbi.2013.06.015","volume":"46","author":"F Vitali","year":"2013","unstructured":"Vitali F, Mulas F, Marini P, Bellazzi R. Network-based target ranking for polypharmacological therapies. J Biomed Inform. 2013;46(5):876\u201381.","journal-title":"J Biomed Inform"},{"issue":"3","key":"4298_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discovery. 2012;11(3):191\u2013200.","journal-title":"Nat Rev Drug Discovery"},{"issue":"10","key":"4298_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1007-1110","volume":"25","author":"AL Hopkins","year":"2007","unstructured":"Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25(10):1110\u20131.","journal-title":"Nat Biotechnol"},{"key":"4298_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang R, Zhu X, Bai H, Ning K. Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol. 2019;10:123.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4298_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.taap.2005.06.021","volume":"212","author":"JF Maddox","year":"2006","unstructured":"Maddox JF, Luyendyk JP, Cosma GN, Breau AP, Bible RH Jr, Harrigan GG, et al. Metabonomic evaluation of idiosyncrasy-like liver injury in rats cotreated with ranitidine and lipopolysaccharide. Toxicol Appl Pharmacol. 2006;212(1):35\u201344.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4298_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37796\/2211-8039.1308","volume":"12","author":"B de Liyis","year":"2022","unstructured":"de Liyis B, Nolan J, Maharjana M. Fibroblast growth factor receptor 1-bound extracellular vesicle as novel therapy for osteoarthritis. Biomedicine. 2022;12(2):1\u20139.","journal-title":"Biomedicine"},{"key":"4298_CR21","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.compbiolchem.2020.107402","volume":"90","author":"X Jiao","year":"2021","unstructured":"Jiao X, Jin X, Ma Y, Yang Y, Li J, Liang L, et al. A comprehensive application: Molecular docking and network pharmacology for the prediction of bioactive constituents and elucidation of mechanisms of action in component-based Chinese medicine. Comput Biol Chem. 2021;90:107402.","journal-title":"Comput Biol Chem"},{"issue":"12","key":"4298_CR22","doi-asserted-by":"publisher","first-page":"i246","DOI":"10.1093\/bioinformatics\/btq176","volume":"26","author":"Y Yamanishi","year":"2010","unstructured":"Yamanishi Y, Kotera M, Kanehisa M, Goto S. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics. 2010;26(12):i246\u201354.","journal-title":"Bioinformatics"},{"issue":"W1","key":"4298_CR23","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4298_CR24","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4298_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"ZJ Yao","year":"2016","unstructured":"Yao ZJ, Dong J, Che YJ, Zhu MF, Wen M, Wang NN, et al. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models. J Comput Aided Mol Des. 2016;30(5):413\u201324.","journal-title":"J Comput Aided Mol Des"},{"issue":"Suppl 2","key":"4298_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12864-016-2722-2","volume":"17","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Plaschkes I, Oz-Levi D, Alkelai A, Olender T, Zimmerman S, et al. VarElect: the phenotype-based variation prioritizer of the GeneCards Suite. BMC Genomics. 2016;17(Suppl 2):444.","journal-title":"BMC Genomics"},{"issue":"1","key":"4298_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4298_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"4298_CR29","doi-asserted-by":"publisher","first-page":"5539970","DOI":"10.1155\/2021\/5539970","volume":"2021","author":"W Yun","year":"2021","unstructured":"Yun W, Dan W, Liu J, Guo X, Li M, He Q. Investigation of the mechanism of traditional Chinese medicines in angiogenesis through network pharmacology and data mining. Evid Based Complement Alternat Med. 2021;2021:5539970.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4298_CR30","doi-asserted-by":"publisher","first-page":"112865","DOI":"10.1016\/j.ecoenv.2021.112865","volume":"227","author":"P Hu","year":"2021","unstructured":"Hu P, Sun N, Khan A, Zhang X, Sun P, Sun Y, et al. Network pharmacology-based study on the mechanism of scutellarin against zearalenone-induced ovarian granulosa cell injury. Ecotoxicol Environ Saf. 2021;227:112865.","journal-title":"Ecotoxicol Environ Saf"},{"key":"4298_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.apcsb.2015.09.004","volume":"102","author":"P Sneha","year":"2016","unstructured":"Sneha P, Doss C. Molecular dynamics: new frontier in personalized medicine. Adv Protein Chem Struct Biol. 2016;102:181\u2013224.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"11","key":"4298_CR32","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"key":"4298_CR33","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4298_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4298_CR35","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.019","volume":"24","author":"A Verma","year":"2015","unstructured":"Verma A, Sharma S. Beneficial effect of protein tyrosine phosphatase inhibitor and phytoestrogen in dyslipidemia-induced vascular dementia in ovariectomized rats. J Stroke Cerebrovasc Dis. 2015;24(11):2434\u201346.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"4298_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jbmr.2435","volume":"30","author":"N Kamiya","year":"2015","unstructured":"Kamiya N, Yamaguchi R, Adapala N, Chen E, Neal D, Jack O, et al. Legg-Calv\u00e9-Perthes disease produces chronic hip synovitis and elevation of interleukin-6 in the synovial fluid. J Bone Miner Res. 2015;30(6):1009\u201313.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"4298_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.31083\/j.fbl2809194","volume":"28","author":"N Calabriso","year":"2023","unstructured":"Calabriso N, Massaro M, Scoditti E, Carluccio C, Verri T, Carluccio M. Epigenetic mechanisms in vascular inflammation: modulation of endothelial adhesion molecules and endothelium-leukocyte adhesion. Front Biosci (Landmark edition). 2023;28(9):194.","journal-title":"Front Biosci (Landmark edition)"},{"issue":"4","key":"4298_CR38","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1073\/pnas.1213480110","volume":"110","author":"M Cox","year":"2013","unstructured":"Cox M, Barnum S, Bullard D, Zajac A. ICAM-1-dependent tuning of memory CD8 T-cell responses following acute infection. Proc Natl Acad Sci USA. 2013;110(4):1416\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"4298_CR39","doi-asserted-by":"publisher","first-page":"7771","DOI":"10.1021\/acsomega.1c00242","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Zhang Y, Liu R, Mai Y. Anagliptin protected against hypoxia\/reperfusion-induced brain vascular endothelial permeability by increasing ZO-1. ACS Omega. 2021;6(11):7771\u20137.","journal-title":"ACS Omega"},{"key":"4298_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fnins.2020.00513","volume":"14","author":"E Pimentel","year":"2020","unstructured":"Pimentel E, Sivalingam K, Doke M, Samikkannu T. Effects of drugs of abuse on the blood-brain barrier: a brief overview. Front Neurosci. 2020;14:513.","journal-title":"Front Neurosci"},{"issue":"6","key":"4298_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.8.6.13","volume":"8","author":"BVD Bogerd","year":"2019","unstructured":"Bogerd BVD, Zakaria N, Adam B, Matthyssen S, Dhubhghaill SN. Corneal endothelial cells over the past decade: are we missing the mark(er)? Transl Vision Sci Technol. 2019;8(6):13.","journal-title":"Transl Vision Sci Technol"},{"issue":"5","key":"4298_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4161\/cc.5.5.2538","volume":"5","author":"P Somanath","year":"2006","unstructured":"Somanath P, Razorenova O, Chen J, Byzova T. Akt1 in endothelial cell and angiogenesis. Cell cycle (Georgetown, Tex). 2006;5(5):512\u20138.","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"11","key":"4298_CR43","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/nm1307","volume":"11","author":"J Chen","year":"2005","unstructured":"Chen J, Somanath P, Razorenova O, Chen W, Hay N, Bornstein P, et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med. 2005;11(11):1188\u201396.","journal-title":"Nat Med"},{"issue":"35","key":"4298_CR44","doi-asserted-by":"publisher","first-page":"12865","DOI":"10.1073\/pnas.1408472111","volume":"111","author":"M Lee","year":"2014","unstructured":"Lee M, Luciano A, Ackah E, Rodriguez-Vita J, Bancroft T, Eichmann A, et al. Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. Proc Natl Acad Sci USA. 2014;111(35):12865\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"4298_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrd3358","volume":"10","author":"J Leiper","year":"2011","unstructured":"Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discovery. 2011;10(4):277\u201391.","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"4298_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.atherosclerosis.2009.07.056","volume":"208","author":"A Al-Isa","year":"2010","unstructured":"Al-Isa A, Thalib L, Akanji A. Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis. 2010;208(2):543\u20139.","journal-title":"Atherosclerosis"},{"issue":"8","key":"4298_CR47","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","volume":"15","author":"D Endemann","year":"2004","unstructured":"Endemann D, Schiffrin E. Endothelial dysfunction. J Am Soc Nephrol. 2004;15(8):1983\u201392.","journal-title":"J Am Soc Nephrol"},{"key":"4298_CR48","doi-asserted-by":"crossref","first-page":"792393","DOI":"10.1155\/2010\/792393","volume":"2010","author":"I van den Oever","year":"2010","unstructured":"van den Oever I, Raterman H, Nurmohamed M, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm. 2010;2010:792393.","journal-title":"Mediators Inflamm"},{"key":"4298_CR49","doi-asserted-by":"publisher","first-page":"569654","DOI":"10.1155\/2012\/569654","volume":"2012","author":"S Funk","year":"2012","unstructured":"Funk S, Yurdagul A, Orr A. Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vascular Med. 2012;2012:569654.","journal-title":"Int J Vascular Med"},{"issue":"4","key":"4298_CR50","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ijms19041057","volume":"19","author":"D Kong","year":"2018","unstructured":"Kong D, Kim Y, Kim M, Jang J, Lee S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018;19(4):1057.","journal-title":"Int J Mol Sci"},{"doi-asserted-by":"crossref","unstructured":"Zhang B, Hao Z, Zhou W, Zhang S, Sun M, Li H, et al. Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPAR-\u03b3 signaling based on network pharmacology and experimental validation. 2021;12(1):4887-98.","key":"4298_CR51","DOI":"10.1080\/21655979.2021.1959493"},{"issue":"12","key":"4298_CR52","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.RES.0000022200.71892.9F","volume":"90","author":"I Shiojima","year":"2002","unstructured":"Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002;90(12):1243\u201350.","journal-title":"Circ Res"},{"issue":"4","key":"4298_CR53","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/ATVBAHA.118.310748","volume":"38","author":"M Lee","year":"2018","unstructured":"Lee M, Gamez-Mendez A, Zhang J, Zhuang Z, Vinyard D, Kraehling J, et al. Endothelial cell autonomous role of Akt1: regulation of vascular tone and ischemia-induced arteriogenesis. Arterioscler Thromb Vasc Biol. 2018;38(4):870\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"4298_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10456-008-9111-7","volume":"11","author":"P Somanath","year":"2008","unstructured":"Somanath P, Chen J, Byzova T. Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis. 2008;11(3):277\u201388.","journal-title":"Angiogenesis"},{"issue":"4","key":"4298_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/bcpt.12094","volume":"113","author":"Z Kang","year":"2013","unstructured":"Kang Z, Zhu H, Jiang W, Zhang S. Protocatechuic acid induces angiogenesis through PI3K-Akt-eNOS-VEGF signalling pathway. Basic Clin Pharmacol Toxicol. 2013;113(4):221\u20137.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5573","key":"4298_CR56","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1126\/science.1071924","volume":"296","author":"G Chen","year":"2002","unstructured":"Chen G, Goeddel D. TNF-R1 signaling: a beautiful pathway. Science (New York, NY). 2002;296(5573):1634\u20135.","journal-title":"Science (New York, NY)"},{"issue":"7","key":"4298_CR57","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.21037\/apm-21-1469","volume":"10","author":"J Xu","year":"2021","unstructured":"Xu J, Zhang Z, Zhou K, Li Y, Wan J, Mao T, et al. Integration of network pharmacology and molecular docking technology reveals the mechanism of the herbal pairing of Codonopsis Pilosula (Franch.) Nannf and Astragalus Membranaceus (Fisch.) Bge on chronic heart failure. Ann Palliative Med. 2021;10(7):7942\u201359.","journal-title":"Ann Palliative Med"},{"issue":"3","key":"4298_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/01.RES.0000137876.28454.64","volume":"95","author":"J Wautier","year":"2004","unstructured":"Wautier J, Schmidt A. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res. 2004;95(3):233\u20138.","journal-title":"Circ Res"},{"issue":"3","key":"4298_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/s-0040-1710045","volume":"29","author":"K Prasad","year":"2020","unstructured":"Prasad K, Bhanumathy K. AGE-RAGE axis in the pathophysiology of chronic lower limb ischemia and a novel strategy for its treatment. Int J Angiology. 2020;29(3):156\u201367.","journal-title":"Int J Angiology."},{"issue":"11","key":"4298_CR60","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","volume":"64","author":"M Pertynska-Marczewska","year":"2015","unstructured":"Pertynska-Marczewska M, Diamanti-Kandarakis E, Zhang J, Merhi Z. Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome? Metabolism. 2015;64(11):1564\u201373.","journal-title":"Metabolism"},{"issue":"9","key":"4298_CR61","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s001250100631","volume":"44","author":"I Obrosova","year":"2001","unstructured":"Obrosova I, Minchenko A, Marinescu V, Fathallah L, Kennedy A, Stockert C, et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia. 2001;44(9):1102\u201310.","journal-title":"Diabetologia"},{"issue":"7","key":"4298_CR62","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/01.CIR.0000051367.92927.07","volume":"107","author":"F Cosentino","year":"2003","unstructured":"Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation. 2003;107(7):1017\u201323.","journal-title":"Circulation"},{"issue":"5","key":"4298_CR63","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3892\/etm.2016.3111","volume":"11","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Liao S, Lu R, Dang H, Zhao J, Ding X. Endothelial nitric oxide synthase gene polymorphism is associated with Legg-Calv\u00e9-Perthes disease. Exp Ther Med. 2016;11(5):1913\u20137.","journal-title":"Exp Ther Med"},{"key":"4298_CR64","doi-asserted-by":"publisher","first-page":"106246","DOI":"10.1016\/j.phrs.2022.106246","volume":"180","author":"FB Felix","year":"2022","unstructured":"Felix FB, Vago JP, Amorim.Beltrami V, Dantas.Ara\u00fajo JM, Grespan R, Teixeira MM, et al. Biochanin A as a modulator of the inflammatory response: an updated overview and therapeutic potential. Pharmacol Res. 2022;180:106246.","journal-title":"Pharmacol Res"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-04298-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04298-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T18:03:09Z","timestamp":1704823389000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-04298-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4298"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-04298-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"type":"electronic","value":"2662-7671"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}